Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (51-60 of 318) with videos related to

Pageof 32
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2021
Sarcopenia in chronic liver disease: easy to diagnose but hard to treatNicola Pugliese, Ezio Lanza, Alessio Aghemo
Kidney & Blood Pressure Research|December 21, 2013
Hepatorenal syndrome and novel advances in its managementFabrizio Fabrizi, Alessio Aghemo, Piergiorgio Messa
Expert Opinion on Drug Safety|February 4, 2015
Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis CRoberta D'Ambrosio, Alessio Aghemo, Massimo Colombo
Clinical Therapeutics|February 15, 2011
A review of the treatment of chronic hepatitis C virus infection in cirrhosisElena Vezali, Alessio Aghemo, Massimo Colombo
Biologics : Targets & Therapy|November 3, 2012
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevirRoberta D'Ambrosio, Alessio Aghemo, Massimo Colombo
Gastroenterology|August 6, 2018
Managing Patients With Nonalcoholic Fatty Liver Disease: Is It Really Only About Fibrosis?Alessio Aghemo, Cesare Berra, Massimo Colombo
Hepatobiliary Surgery and Nutrition|May 11, 2018
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenarioLuca Viganò, Ana Lleo, Alessio Aghemo
Clinics in Liver Disease|July 11, 2017
Treatment of Extrahepatic Manifestations of Hepatitis C VirusElisabetta Degasperi, Alessio Aghemo, Massimo Colombo
Journal of the International AIDS Society|April 11, 2018
What do clinicians need to watch for with direct-acting antiviral therapy?Alessio Aghemo, Lionel Piroth, Sanjay Bhagani
Expert Opinion on Pharmacotherapy|November 10, 2015
Daclatasvir for the treatment of chronic hepatitis CElisabetta Degasperi, Alessio Aghemo, Massimo Colombo
Pageof 32

Showing results (51-60 of 318) with videos related to

Sort By:
Pageof 32
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2021
Sarcopenia in chronic liver disease: easy to diagnose but hard to treatNicola Pugliese, Ezio Lanza, Alessio Aghemo
Kidney & Blood Pressure Research|December 21, 2013
Hepatorenal syndrome and novel advances in its managementFabrizio Fabrizi, Alessio Aghemo, Piergiorgio Messa
Expert Opinion on Drug Safety|February 4, 2015
Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis CRoberta D'Ambrosio, Alessio Aghemo, Massimo Colombo
Clinical Therapeutics|February 15, 2011
A review of the treatment of chronic hepatitis C virus infection in cirrhosisElena Vezali, Alessio Aghemo, Massimo Colombo
Biologics : Targets & Therapy|November 3, 2012
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevirRoberta D'Ambrosio, Alessio Aghemo, Massimo Colombo
Gastroenterology|August 6, 2018
Managing Patients With Nonalcoholic Fatty Liver Disease: Is It Really Only About Fibrosis?Alessio Aghemo, Cesare Berra, Massimo Colombo
Hepatobiliary Surgery and Nutrition|May 11, 2018
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenarioLuca Viganò, Ana Lleo, Alessio Aghemo
Clinics in Liver Disease|July 11, 2017
Treatment of Extrahepatic Manifestations of Hepatitis C VirusElisabetta Degasperi, Alessio Aghemo, Massimo Colombo
Journal of the International AIDS Society|April 11, 2018
What do clinicians need to watch for with direct-acting antiviral therapy?Alessio Aghemo, Lionel Piroth, Sanjay Bhagani
Expert Opinion on Pharmacotherapy|November 10, 2015
Daclatasvir for the treatment of chronic hepatitis CElisabetta Degasperi, Alessio Aghemo, Massimo Colombo
Pageof 32